BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11472565)

  • 1. Gastrointestinal stromal tumors and KIT-positive mesenchymal cells in the omentum.
    Sakurai S; Hishima T; Takazawa Y; Sano T; Nakajima T; Saito K; Morinaga S; Fukayama M
    Pathol Int; 2001 Jul; 51(7):524-31. PubMed ID: 11472565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M; Sobin LH; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal.
    Sakurai S; Fukasawa T; Chong JM; Tanaka A; Fukayama M
    Am J Pathol; 1999 Jan; 154(1):23-8. PubMed ID: 9916914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of GIST/GIPACT tumors by inmunohistochemistry and exon 11 analysis of c-kit by PCR.
    Bernet L; Zuñiga A; Cano R
    Rev Esp Enferm Dig; 2003 Oct; 95(10):688-91, 683-7. PubMed ID: 14588063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-kit gene mutation at exon 17 or 13 is very rare in sporadic gastrointestinal stromal tumors.
    Kinoshita K; Isozaki K; Hirota S; Nishida T; Chen H; Nakahara M; Nagasawa Y; Ohashi A; Shinomura Y; Kitamura Y; Matsuzawa Y
    J Gastroenterol Hepatol; 2003 Feb; 18(2):147-51. PubMed ID: 12542597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors.
    Sircar K; Hewlett BR; Huizinga JD; Chorneyko K; Berezin I; Riddell RH
    Am J Surg Pathol; 1999 Apr; 23(4):377-89. PubMed ID: 10199467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases.
    Miettinen M; Furlong M; Sarlomo-Rikala M; Burke A; Sobin LH; Lasota J
    Am J Surg Pathol; 2001 Sep; 25(9):1121-33. PubMed ID: 11688571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large omental metastases of a gastrointestinal stromal tumor.
    Ignatavičius P; Petraitis T; Saladžinskas Z; Butkevičienė L; Zvinienė K
    Medicina (Kaunas); 2011; 47(11):600-3. PubMed ID: 22207167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases.
    Miettinen M; Monihan JM; Sarlomo-Rikala M; Kovatich AJ; Carr NJ; Emory TS; Sobin LH
    Am J Surg Pathol; 1999 Sep; 23(9):1109-18. PubMed ID: 10478672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PKC theta, a novel immunohistochemical marker for gastrointestinal stromal tumors (GIST), especially useful for identifying KIT-negative tumors.
    Motegi A; Sakurai S; Nakayama H; Sano T; Oyama T; Nakajima T
    Pathol Int; 2005 Mar; 55(3):106-12. PubMed ID: 15743318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors.
    Lux ML; Rubin BP; Biase TL; Chen CJ; Maclure T; Demetri G; Xiao S; Singer S; Fletcher CD; Fletcher JA
    Am J Pathol; 2000 Mar; 156(3):791-5. PubMed ID: 10702394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-kit gene abnormalities in gastrointestinal stromal tumors (tumors of interstitial cells of Cajal.
    Sakurai S; Fukasawa T; Chong JM; Tanaka A; Fukayama M
    Jpn J Cancer Res; 1999 Dec; 90(12):1321-8. PubMed ID: 10665649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors.
    Kim TW; Lee H; Kang YK; Choe MS; Ryu MH; Chang HM; Kim JS; Yook JH; Kim BS; Lee JS
    Clin Cancer Res; 2004 May; 10(9):3076-81. PubMed ID: 15131046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression.
    Tang CM; Lee TE; Syed SA; Burgoyne AM; Leonard SY; Gao F; Chan JC; Shi E; Chmielecki J; Morosini D; Wang K; Ross JS; Kendrick ML; Bardsley MR; Siena M; Mao J; Harismendy O; Ordog T; Sicklick JK
    Oncotarget; 2016 Nov; 7(48):78226-78241. PubMed ID: 27793025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal stromal tumors and leiomyosarcomas in the colon: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases.
    Miettinen M; Sarlomo-Rikala M; Sobin LH; Lasota J
    Am J Surg Pathol; 2000 Oct; 24(10):1339-52. PubMed ID: 11023095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course.
    Lasota J; Dansonka-Mieszkowska A; Stachura T; Schneider-Stock R; Kallajoki M; Steigen SE; Sarlomo-Rikala M; Boltze C; Kordek R; Roessner A; Stachura J; Miettinen M
    Mod Pathol; 2003 Dec; 16(12):1257-64. PubMed ID: 14681327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of c-kit gene mutation on prognosis of gastrointestinal stromal tumor].
    Ma DL; Liu XH; Bai CG; Xie Q; Feng F
    Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):140-4. PubMed ID: 15062057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity.
    Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R
    J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review.
    Miettinen M; Majidi M; Lasota J
    Eur J Cancer; 2002 Sep; 38 Suppl 5():S39-51. PubMed ID: 12528772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in exon 11 of the c-kit gene in a myogenic tumor and a neurogenic tumor as well as in gastrointestinal stromal tumors. Utility of c-kit mutation as a prognostic biomarker for gastrointestinal mesenchymal tumor.
    Yasuoka R; Sakakura C; Shimomura K; Fujita Y; Nakanishi M; Aragane H; Hagiwara A; Bamba M; Abe T; Yamagishi H
    Dig Surg; 2003; 20(3):183-91. PubMed ID: 12759497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.